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the mechanical forces experienced during 
mastication. Periodontitis is a chronic 
inflammatory disease initiated by an 
oral bacterial biofilm, which results 
in periodontal hard and soft tissues 
destruction and can lead to tooth loss. It 
affects 30–40% of the population[1] and the 
large impact and burden of this disease on 
individuals and the community is well rec-
ognized not only in terms of compromised 
quality of life, but also overall health and 
systemic well-being.[2]
1.1. The Unique Challenges Faced  
in Achieving Periodontal Regeneration
The ultimate objective of periodontal treat-
ment is regeneration of the lost tissues of 
the periodontium, which involves the func-
tional reattachment of the periodontal liga-
ment onto newly formed cementum and 
alveolar bone. This requires a highly coor-
dinated spatiotemporal healing response, 
including cementogenesis concomitant 
with periodontal ligament fiber reattach-
ment to the previously contaminated root surface, as well as 
bone formation within the periodontal defect (Figure 1). In addi-
tion to the challenges posed by the complex architecture of the 
periodontium, healing is further complicated by the avascular 
nature of the tooth surface, which means that all periodontal 
wound healing occurs by secondary intention. Furthermore, 
The periodontium, consisting of gingiva, periodontal ligament, cementum, 
and alveolar bone, is a hierarchically organized tissue whose primary role 
is to provide physical and mechanical support to the teeth. Severe cases 
of periodontitis, an inflammatory condition initiated by an oral bacterial 
biofilm, can lead to significant destruction of soft and hard tissues of the 
periodontium and result in compromised dental function and aesthetics. 
Although current treatment approaches can limit the progression of the 
disease by controlling the inflammatory aspect, complete periodontal 
regeneration cannot be predictably achieved. Various tissue engineering 
approaches are investigated for their ability to control the critical temporo-
spatial wound healing events that are essential for achieving periodontal 
regeneration. This paper reviews recent progress in the field of periodontal 
tissue engineering with an emphasis on advanced 3D multiphasic tissue 
engineering constructs (TECs) and provides a critical analysis of their 
regenerative potential and limitations. The review also elaborates on the 
future of periodontal tissue engineering, including scaffold customization for 
individual periodontal defects, TEC’s functionalization strategies for imparting 
enhanced bioactivity, periodontal ligament fiber guidance, and the utilization 
of chair-side regenerative solutions that can facilitate clinical translation.
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1. Introduction
The periodontium is a highly hierarchical organ consisting 
of intercalated soft (gingival and periodontal ligament) and 
hard (cementum and alveolar bone) tissues that mechanically 
support the teeth and play an important role in transmitting 
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healing is additionally compromised by the presence of intraoral 
bacteria at the nonshedding tooth surface, which can nega-
tively affect the wound healing process following periodontal 
treatment.
1.2. Historical Perspective of Periodontal Regeneration 
Approaches
In the 1970s, the concept involving the utilization of a physical 
barrier for preventing epithelial downgrowth along the tooth 
root surface following the surgical treatment of periodontitis 
was in its genesis (Figure 2). Indeed, clinicians had previously 
hypothesized and conceptualized that the collapse of gingival 
tissues into the periodontal defects significantly impeded bone 
regeneration and periodontal reattachment.[3,4] Some early 
studies proposed the placement of a harvested free palatal 
graft over the periodontal defect in an attempt to hinder or at 
least delay the downgrowth of epithelial cells along the tooth 
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root surface.[5] Another commonly utilized approach involved 
the placement of bone fillers (autologous, allogenic, or syn-
thetic) within the periodontal defect in order to regenerate the 
lost bone.[6] However, none of these approaches resulted in the 
new attachment formation required for periodontal regenera-
tion, and only periodontal repair was observed in the form of a 
long junctional epithelium. Retrospectively, it can be concluded 
from the large experimental and clinical data sets that the 
lack of compartmentalization between the periodontal defect 
and the surrounding soft tissue was responsible for the poor 
regenerative outcomes.
The issue of selective periodontal defect repopulation by 
tissues capable of promoting periodontal regeneration was 
addressed in a series of seminal papers by Nyman et al., 
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Figure 1. Schematic representation of the biological events leading to 
either periodontal healing or periodontal regeneration in the presence of 
a GTR membrane involving concomitant deposition of new cementum, 
bone regeneration, and periodontal reattachment for functional 
regeneration.
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which led to the establishment of the concept of guided tissue 
regeneration (GTR). This elegant approach involves the use 
of a synthetic membrane to exclude undesirable tissues (gin-
gival epithelium and connective tissue) from the healing 
periodontal wound, while selectively promoting the in-growth 
of the periodontal ligament and bone tissues required for 
achieving periodontal regeneration[7] (as depicted in Figure 1). 
Using GTR, Nyman et al. histologically demonstrated the for-
mation of new functional attachment of periodontal ligament 
fibers into newly formed cementum on the root surface of a 
human mandibular incisor.[7a] The effectiveness of this clinical 
technique was further confirmed several years later by Gottlow 
et al., who successfully applied it to a larger cohort of patients.[8] 
Subsequently, the scientific and biological rationale of GTR 
have been validated over the last three decades in many publi-
cations,[9] and efficacy of the technique has been demonstrated 
in a plethora of clinical studies[10] and reported in systematic 
reviews.[11] As a result, the pioneering work with the subse-
quent large-scale clinical translation has profoundly shaped 
the future developments in periodontal regeneration. Indeed, 
the principles of GTR, namely wound stabilization, space 
maintenance, and selective cell repopulation, often neglected 
by so-called tissue engineers, yet remain key design considera-
tions in any tissue engineering approaches aimed at enhancing 
periodontal regeneration.
1.3. Challenges in GTR and Periodontal Healing
GTR became a standard surgical treatment for periodontal 
regeneration; however, despite histologically verified regen-
eration and positive outcomes in selected clinical scenarios, 
there still exists a significant variability in the clinical effi-
cacy of the technique.[11] Indeed, GTR remains unpredictable 
and clinical outcomes vary depending on the nature of the 
periodontal defect and the skills and experience of the prac-
titioner.[9] The challenging environment of the oral cavity is 
at least partly responsible for the poor regeneration observed 
in GTR procedures; indeed, it is an “open” wound adjacent 
to an avascular surface (the tooth), which is subject to micro-
bial challenge from the resident intraoral microbial biofilm.[12] 
In addition, the periodontium has a very specific and highly 
hierarchal anatomy, and as such, requires well-coordinated 
healing sequences in order to achieve complete regenera-
tion via the restoration of the complex periodontal architec-
ture. These challenges are relatively poorly addressed in GTR 
procedures, as autologous progenitor cells may repopulate 
the periodontal defect at random time intervals and locations 
without a specific and temporal course of events whereby new 
cementum, ligament, and bone are formed in sequential and 
overlapping phases. As a result, complete regeneration, con-
sisting of concomitant 1) new cementum deposition, 2) perio-
dontal ligament (PDL) attachment with insertion of Sharpey’s 
fibers into the cementum, and 3) bone formation,[4] is rarely 
and unpredictably achieved.[9] Scar tissue is often formed 
in lieu of a functional periodontal ligament which does not 
resemble the structure, nor recapitulate the function, of the 
native tissue.
It is clear that periodontal regeneration has unique chal-
lenges from both a biological (spatiotemporal healing coor-
dination, competition between the tissues, and nonvascular 
tooth surface preventing primary closure) and from a clinical 
point of view (microbial accumulation on nonshedding tooth 
surface, technically challenging surgical environment due to 
limited access and small operating field). Hence, a tissue engi-
neering approach, utilizing advanced 3D scaffold architectures, 
combined with bioactive molecules, drugs, gene therapy, and/
or cell delivery, that have the ability to guide and coordinate the 
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Figure 2. Historical timeline of the development of barrier/membrane and scaffold-based periodontal regeneration approaches aimed to exert 
temporo-spatial coordination of the periodontal wound healing process: from the initial concept involving a free palatal graft for impeding epithelial 
migration, via the clinical implementation of the GTR concept utilizing occlusive membranes, to the most recent clinical advancements involving 
additively manufactured polymeric multiphasic scaffolds for periodontal tissue engineering.
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healing process, is scientifically sound and has the potential to 
circumvent many limitations associated with current clinical 
practice.[13] These tissue engineering constructs (TECs) should 
fulfill the requirements of GTR (space maintenance, wound 
stabilization, and selective cell repopulation) while enabling 
spatiotemporal control of the periodontal wound healing pro-
cess. Such tissue engineered TECs should not only be made 
of a biodegradable biomaterial with proven clinical biocompat-
ibility, yet also highly porous with an interconnected porosity 
for allowing the formation of a stable fibrin network within 
the blood clot and subsequently enabling cell infiltration and 
finally tissue formation with a well-developed vascular network.
Importantly, the degradation kinetics of the scaffold should 
be tailored, based on the timeframe required for the preser-
vation of space maintenance properties until a dimensionally 
stable new tissue has formed.
This review reports on the recent advancements in tissue 
engineering strategies for periodontal regeneration, with 
a strong and critical focus on 3D multiphasic constructs 
incorporating compartmentalized designs for achieving the 
aforementioned spatiotemporal coordination of the periodontal 
wound healing events.
2. Monophasic Scaffolds
The development of scaffolds for periodontal regeneration was 
inspired by current clinical practice (namely GTR) whereby 
a biomaterial is utilized in order to maintain space[14] and 
promote new periodontal tissue formation within the defect. 
Therefore, a variety of monophasic TECs have been developed 
which followed the principles of GTR. Additionally, bioactivity 
is imparted to these TECs through the use of either inorganic 
fillers and/or biological adjuvants for promoting bone and/or 
ligament formation.
2.1. Monophasic Scaffolds for Cell Delivery
An obvious technique for increasing the regenerative poten-
tial of biomaterial constructs is the introduction of cells from 
various sources. This approach is well documented in the litera-
ture whereby cells are either encapsulated in various hydrogel 
systems or seeded into scaffolds and then transplanted into 
the periodontal defect. In addition to the capacity of the 
monophasic scaffold to maintain space, it also acts as a car-
rier for delivering cells within the periodontal defect. While the 
concept may appear to be relatively simple, its implementation 
has resulted in variable outcomes depending on the scaffold 
biomaterial and the type of cells used.
Several recently published studies have utilized rapidly 
resorbing materials in either preclinical[15] or clinical studies.[16] 
A notable clinical example combined osteogenically induced 
bone marrow-derived mesenchymal stem cells with a platelet-
rich plasma (PRP) preparation which was infused into a 
poly-l-lactic acid knitted mesh (Figure 3A).[16] This malleable, 
cellularized TECs was thereafter implanted into periodontal 
defects of ten patients and resulted in some improvements 
in clinical outcomes, such as clinical attachment level, pocket 
depth, and linear bone growth (Figure 3A).
Conceptually, for the successful regeneration of complex 
organs such as the periodontium which incorporate a hard 
tissue component, a mature bony tissue should be formed 
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Figure 3. Monophasic scaffolds for cell delivery: A) utilization of a PLLA mesh loaded with bone marrow mesenchymal stem cells in a clinical trial involving ten 
patients, resulting in significant improvements of clinical parameters such as increased bone height (as indicated by the white arrows). Reproduced with permis-
sion under the terms of the CC-BY 4.0 license.[16] Copyright 2016, the Authors. Published by Hindawi Publishing Corporation. B) Melt electrospun scaffold used 
for the support and delivery of trilayered cell sheets in a rat periodontal defect. The macroporous structure of the electrospun scaffold enabled bone ingrowth 
and integration with the newly formed periodontal ligament (nb: new bone; Sc: scaffold; d: dentin). Reproduced with permission.[17] Copyright 2014, Elsevier.
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before the complete degradation of the biomaterial so that long-
term dimensional stability of the regenerated tissue is achieved. 
Therefore, a slowly degrading material is preferable. This can 
be achieved by the utilization of a medical grade polycaprolac-
tone melt electrospun membrane in combination with mature 
cell sheets of various tissue origins, as Dan et al. recently dem-
onstrated in a surgically created rodent periodontal defect.[17] 
Indeed, the calcium phosphate–coated melt electrospun scaf-
fold, consisting of 20 µm diameter microfibers organized 
in a macroporous network (Figure 3B), enabled the place-
ment of cell sheets in intimate contact with the root surface 
while allowing for the space maintenance necessary for bone 
ingrowth and periodontal ligament regeneration (Figure 3B).[17]
It should be noted that cell-based periodontal therapies have 
limitations associated with considerable regulatory barriers 
related to cell source and harvesting, culture, etc.; however, the 
development of advanced scaffolds made of synthetic bioma-
terials and loaded with drugs or growth factors has the poten-
tial to provide interesting solutions toward clinical translation 
without a cellular component.
2.2. Monophasic Scaffolds for Growth Factor Delivery
Synthetic polymers with extended biodegradation profiles and 
enhanced mechanical properties have been utilized for the 
delivery of growth factors. Although the incorporation of bio-
logical cues directly into the bulk of the scaffold is challenging 
due to material processing requirements (high temperature and 
strong organic solvent potentially leading to denaturation of bio-
logical components), the strategy of using microspheres as the 
delivery vehicle has found widespread use in tissue engineering 
applications, including periodontal regeneration. Such an 
approach was implemented for the dual and sequential delivery 
of platelet-derived growth factor (PDGF) and simvastatin.[18] 
This was achieved by developing double-wall microspheres 
manufactured by coaxial electrospraying of poly-(d,l-lactide-co-
glycolide) and poly-(d,l-lactide) solutions, incorporating simvas-
tatin (used as a differentiation factor) in the core and PDGF in 
the shell (Figure 4A). This technique allowed for better control 
over the release profile, allowing more sustained delivery when 
compared to simpler biomaterial systems such as collagen gels, 
whereby a rapid release generally occurs within the first hours. 
The microspheres displayed a sustained release of PDGF over 
14 days while only half of the simvastatin was released over that 
time period.[19] Subsequently, the regenerative performance of 
the microspheres was tested in a rat periodontal defect model, 
and this demonstrated the beneficial influence of the dual 
release system on osteogenesis (Figure 4B), as well as cemen-
togenesis and the formation of perpendicularly inserting newly 
formed ligament fibers[18] (Figure 4C).
Another approach utilized PLGA microspheres loaded 
with growth factors, which were incorporated into poly-
caprolactone and 3D printed using a melt extrusion printer[20] 
(Figure 4D–H). The embedding of the microspheres into the 
additively manufactured TECs drastically modified the release 
profile of the encapsulated drugs (BMP-2, BMP-7, and con-
nective tissue growth factor (CTGF)), which reached only 
50% release after 42 days (Figure 4F). An ex vivo model was 
utilized in order to investigate the impact of the growth fac-
tors onto cementum and periodontal ligament formation. This 
involved the culture of CD146 positive periodontal ligament 
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Figure 4. Monophasic synthetic scaffolds for drug delivery. A) Morphology of microspheres utilized for the dual delivery of bioactive molecules. 
B) Bone formation induced by the combined delivery of PDGF and simvastatin in three-wall periodontal defects in rats. C) Histology of the regenerated 
periodontium demonstrating evidence of cementogenesis, and formation of perpendicularly oriented periodontal ligament fibers. Reproduced with 
permission.[18] Copyright 2013, Elsevier. D–H) Growth factor–loaded microspheres incorporated into monophasic 3D-printed scaffold. (D) Morphology 
of the 3D-printed scaffold. (E) Distribution of the microspheres within the printed polymer filament. (F) Sustained release of several growth factors. 
(G) Ex vivo model for cementogenesis assessment. (H) Deposition of a mineralized tissue CEMP1 positive in the presence of BMP-7. Reproduced with 
permission.[20] Copyright 2016, Taylor & Francis.
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cells over 6 weeks in the constructs which were placed in direct 
contact with a human dentin slice (Figure 4G). Three dif-
ferent growth factors were tested (CTGF, BMP-2, and BMP-7), 
demonstrating that although the BMPs induced mineraliza-
tion at the dentin interface, only BMP-7 resulted in deposition 
of the cementum specific marker CEMP-1 within the miner-
alized layer (Figure 4H). In the context of periodontal regen-
eration, cementum formation is an essential requirement for 
new periodontal attachment formation and, as such, should 
occur during the early phase of the wound healing process. 
Therefore, a significantly delayed release of biological cues, as 
shown in this study, could result in cementogenesis only in the 
later phases of wound healing, which could compromise the 
insertion and attachment of the ligament fibers onto the root 
surface. Another potential concern is that the sustained release 
of biological cues that promotes hard tissue formation could 
result in a direct union of bone with the tooth surface without 
an intervening periodontal ligament, which is an undesirable 
clinical phenomenon known as ankylosis.
As shown here, previous research has focused on the 
delivery of biochemical cues targeted toward soft and/or hard 
tissue regeneration. However, another important aspect to 
consider in periodontal healing is to address the bacterial 
challenge that originates from the exposure of the wound to 
intraoral fluids. A recent study by our group has proposed the 
utilization of an antibiotic loaded membrane manufactured 
by electrospinning.[21] In this approach, the antimicrobial and 
immunomodulatory drug azithromycin was deposited over 
the surface of the electrospun fibers, resulting in a sustained 
release over several weeks. The loaded membranes were tested 
in a rat calvarial defect model, and it was demonstrated that 
the immunomodulatory properties of the azithromycin loaded 
membrane led to enhanced bone formation. Hence, this 
strategy could potentially both enhance tissue regeneration and 
protect from bacterial contamination.
2.3. Monophasic Scaffolds Loaded with Bioactive Natural 
Materials
Additive manufacturing is a well-suited method for the prepa-
ration of scaffolds with controlled internal porous architecture, 
as well as excellent biomechanical and space maintenance 
properties. Nevertheless, most synthetic polymers have poor 
bioactivity, and hence apart from the physical properties that 
they impart to the TECs (i.e., space maintenance), they do not 
contribute actively in the initiation of the regenerative processes. 
Hence, the incorporation of a biopolymer into these poly-
meric constructs has been proposed in order to create a com-
posite scaffold with enhanced bioactivity. Such a strategy was 
explored by Puppi et al. whereby a highly porous hydroxyapa-
tite-polycaprolactone scaffold was manufactured by coupling 
wet spinning and 3D printing prior to infiltrating a mixture of 
chitosan and poly(γ-glutamic acid) within the porous network of 
the PCL construct.[22] The composite scaffold was subsequently 
freeze-dried and this resulted in the excellent integration of 
the two components at the macro- and microscopic scale. In 
addition, the presence of chitosan within the composite scaf-
fold imparted antimicrobial properties, which were assessed 
on both Gram-positive and Gram-negative bacteria, and it was 
demonstrated that the initial rate of bacterial growth within the 
first 8 h was drastically reduced. Although the scaffold was not 
tested in vivo, the antimicrobial effect imparted by the chitosan 
may enhance periodontal regeneration by preventing bacterial 
contamination of the construct after implantation. However, 
the stiffness of the 3D-printed composite could result in a low 
adaptability to the root surface in the clinical setting, as well 
as contributing to a rigidity mismatch with the overlying soft 
tissues that can lead to gingival perforation.
Another interesting approach involved the utilization of ace-
mannan, a natural polysaccharide extracted from aloe vera.[23] 
This natural product was also manufactured by freeze-drying in 
order to create a sponge (Figure 5A), which was subsequently 
tested in class II furcation defects in dogs. This approach dem-
onstrated enhanced periodontal regeneration at 30 and 60 days 
postimplantation with extensive new cementum deposition 
(up to 80% of the root surface), increased periodontal attach-
ment and nearly full bone height recovery (Figure 5B). This 
study provided an interesting insight into the utilization of 
herbal-derived products for the regeneration of the periodontal 
complex. Although the exact mechanisms resulting in the 
positive influence of accecaman are not known, the authors 
reported excellent blood clot retention of the sponge, which was 
speculated to enhance wound stability and growth factor reten-
tion within the wound. Although the resorption of the sponge 
was not systematically investigated, the in vivo study revealed 
rapid degradation of the polysaccharide as no remnants of 
the material were observed 30 days postimplantation. The loss of 
the space-maintaining properties could compromise the healing 
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Figure 5. Monophasic scaffold incorporating natural material extracted 
from plants. A) Accecaman, a polysaccharide extracted from aloe Vera, is 
processed into a porous sponge. B) Regenerative outcome of the sponge 
in a class II furcation defect in dog, demonstrating the formation of 
new cementum (black arrowhead), bone formation (NB), and ligament 
attachment. Reproduced with permission.[23] Copyright 2014, John Wiley 
and Sons (PB denotes the preexisting bone).
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in more challenging, less contained defects and therefore could 
be an impediment toward successful clinical translation.
The regeneration of the periodontium requires a synchro-
nized wound healing response which may not be achieved by 
the utilization of simple monophasic scaffold architectures. 
Indeed, the hierarchical structure of the native tissue requires 
the regeneration of cementum, ligament, and alveolar bone, 
while monophasic scaffolds generally exert control over the 
formation of a single tissue component, which is usually bone. 
The lack of integrated and coordinated regeneration events of 
the different tissues can be circumvented by scaffold compart-
mentalization, capable of managing the reconstruction of soft 
and hard tissue, and most importantly, their interface.
3. Multiphasic Scaffolds
The complex architecture of the periodontium requires a highly 
coordinated regeneration process, whereby each individual com-
ponent (cementum, ligament, and alveolar bone) regenerates 
according to specific, sometimes overlapping, spatiotemporal 
sequences. Therefore, the utilization of multiphasic constructs, 
recapitulating the native tissue architecture, has recently been 
advocated as the way forward for periodontal regeneration.[13a] 
A multiphasic TEC is generally defined as possessing multiple 
distinguishable compartments of different architectural 
nature (pore size, pore shape, porosity, etc.) and/or biochem-
ical composition. Multiphasic scaffolds are particularly suited 
for tissue engineering of complex structures such as soft–hard 
tissue interfaces, and in the context of periodontal regen-
eration, they can be utilized to mimic the organization of the 
periodontium complex (alveolar bone, PDL, and cementum). As 
such, multiphasic scaffolds for periodontal regeneration strongly 
focus on functional biomimicry to address the challenges posed 
by the soft–hard tissue interfaces between alveolar bone–ligament 
and ligament–cementum. This approach is aimed at facilitating 
functional regeneration and integration of the various periodontal 
components, and more importantly of the newly formed tissues 
at the interfaces aforementioned. In other words, these constructs 
are required to allow for spatially compartmentalized bone, peri-
odontal ligament, and cementum formation, while facilitating, 
via their architecture/biochemical composition at the interfaces, 
the integration of the ligament into both bone and cementum. 
In addition, multiphasic scaffolds must facilitate selective cell 
repopulation and wound stabilization, as well as having appro-
priate space maintenance properties to facilitate the formation of 
functional tissues that are dimensionally stable over time.
Although scaffold compartmentalization appears to be a well-
suited strategy for periodontal tissue engineering, there are a 
very few studies that have explored this approach. These studies 
can be divided into those that have utilized either biphasic or 
triphasic TECs.
3.1. Biphasic Scaffolds
Carlos-Reis et al. developed a biphasic scaffold directly inspired 
from the requirements of GTR.[24] In this strategy, an osteo-
conductive polylactide-co-glycolic (PLGA)–calcium phosphate 
(CaP) composite foam (bone compartment) was utilized in con-
junction with an occlusive PLGA/CaP membrane. The PLGA/
CaP foam was fabricated by dispersing the CaP particles into a 
PLGA solution prior to performing solvent casting into a sugar 
template which was subsequently leached out in water. The 
incorporation of the PLGA membrane was achieved by placing 
the resulting foam onto a CaP/PLGA solution immediately 
prior to complete solvent evaporation, ensuring a strong cohe-
sion between the various components. This biphasic scaffold 
was tested using a canine class II furcation defect with the 
foam facing the tooth root and the membrane providing cell 
and tissue occlusion. This resulted in histologically verified 
periodontal regeneration featuring newly formed ligament 
inserted into cementum, whereas control specimens only 
displayed scar tissue.
In a similar design, Requicha et al. developed a biphasic 
scaffold consisting of a porous fibrous PCL/starch scaffold for 
allowing bone ingrowth and an occlusive membrane made of 
the same material.[25] Here again, the occlusive membrane was 
designed to support periodontal ligament regeneration by pre-
venting epithelial and gingival tissue invasion of the periodontal 
defect, hence selectively favoring osteoblast and periodontal 
fibroblast ingrowth, according to the principles of GTR. In 
addition, in vitro evaluation revealed a high potential for osteo-
genesis, an important feature for periodontal regeneration.[26]
While these approaches were inspired by current clinical 
practices, involving the utilization of an osteoconductive filler 
and a barrier membrane to allow for selective cell repopulation, 
recent papers have more specifically addressed bone and PDL 
compartmentalization, in order to exert greater influence on 
the soft–hard tissue interfaces.
To this end, Park et al. proposed the utilization of addi-
tive manufacturing technology in an indirect manner for the 
development of a biphasic scaffold consisting of bone and liga-
ment compartments.[27] This approach, involving computer-
assisted design and manufacturing (CAD/CAM), utilizing 
two different sacrificial materials in order to 3D print a mold 
carrying the negative imprint of the scaffold design. There-
after, polymer solutions specific to each compartment (polyg-
lycolic acid and polycaprolactone for bone and ligament com-
partment, respectively) were casted in these molds, and the 
solvent was evaporated prior to removing the sacrificial mate-
rial. This resulted in the manufacturing of a porous scaffold of 
defined dimensions and shape with a well-controlled internal 
pore architecture. As the two compartments are separately 
manufactured, they were subsequently assembled using a 
thin PCL film, thus resulting in the creation of a biphasic scaf-
fold. The authors utilized fibrin to deliver BMP-7 transfected 
human gingival fibroblasts and human periodontal fibro-
blasts into the bone and periodontal ligament compartments, 
respectively. The performance of the cellularized biphasic 
scaffold was assessed using a murine ectopic model whereby 
a human dentin block was placed in direct contact with the 
periodontal ligament compartment. This demonstrated that 
the presence of periodontal cells greatly facilitated the attach-
ment of a newly formed ligament onto the dentin slice along 
with the deposition of cementum-like tissue 6 weeks postim-
plantation. In a subsequent study, the manufacturing tech-
nique was slightly modified in order to achieve a higher level 
Adv. Healthcare Mater. 2018, 7, 1800457
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of porosity within the ligament compartment while simultane-
ously providing topographical tissue guidance for periodontal 
fiber orientation and attachment.[28] This was spontaneously 
achieved by casting a PCL solution in the additively manufac-
tured mold, resulting in the formation of microchannels in the 
periodontal compartment, as shown in Figure 7A. The perfor-
mance of the fiber-guiding scaffold was assessed using a sur-
gically created periodontal defect in immunocompromised rats 
and this demonstrated that the presence of the microchannels 
on the surface of the periodontal compartment was effective in 
guiding the newly formed periodontal ligament fibers to insert 
into the root surface at an angle resembling that of native peri-
odontal tissue. Both of these studies relied on the regenerative 
capacity of freshly seeded/delivered cells, introduced into the 
TECs a few hours prior to implantation, to subsequently pro-
liferate, differentiate, and produce ECM that contributed to 
in vivo tissue regeneration. This was further enhanced in the 
bone compartment by delivering transfected cells expressing 
BMP-7, a growth factor that promotes osteogenesis. Although 
these strategies resulted in ectopic periodontal regeneration the 
multiple manufacturing steps and the complexity of the process 
may potential impair commercially viable clinical translation.
The implantation of a well-developed and in vitro matured 
ECM has also been explored in combination with a biphasic 
scaffold.[29,30] To this end, additive manufacturing was utilized 
in order to fabricate a biphasic scaffold. The bone compartment 
consisted of a 3D-printed PCL scaffold, produced via fused 
deposition modeling (FDM), which was subsequently com-
bined with a periodontal ligament compartment, consisting of 
a solution electrospun membrane for supporting and delivering 
mature PDL cell sheets (Figure 6B). In this study,[29] the various 
compartments were separately manufactured and subsequently 
assembled by partially melting the first layer of the FDM scaf-
fold and then press-fitting the solution electrospun membrane. 
The resulting heat transfer between the 3D-printed scaffold 
and the fibrous membrane enabled the partial melting of the 
electrospun fibers which fused to the struts of the bone com-
partment, thus creating a strong adhesion while maintaining 
a porous interface. This biphasic scaffold enabled the culture 
of osteoblasts in the bone compartment while cell sheets, 
separately grown, were attached to the periodontal compart-
ment. The in vivo assessment of this cellularized TECs was 
investigated using an ectopic periodontal regeneration model, 
whereby a dentin slice was positioned in contact with the cell 
sheet and implanted subcutaneously in immunocompromised 
rats. Histological assessment demonstrated that the presence of 
the cell sheets was essential for cementum deposition on the 
dentin surface. However, the partially cell occlusive nature of 
the periodontal compartment made of an electrospun mem-
brane may be considered as a limitation, potentially impeding 
the integration of the newly formed periodontal ligament into 
the new bone. Hence, in a subsequent study,[30] the periodontal 
compartment consisted of a melt electrospun membrane with a 
macroscaled pore size, which was not cell occlusive (Figure 6C). 
Implantation of the modified biphasic TECs seeded with osteo-
blasts and periodontal fibroblast cell sheets using the same 
ectopic periodontal regeneration model confirmed the central 
role of the cell sheet for PDL fiber attachment. Importantly, the 
increased pore size of the periodontal compartment enabled 
ligament-like tissue insertion into the newly formed bone 
(Figure 6C). In addition, the specific organization of the melt 
electrospun scaffold (periodontal compartment) composed 
of concentrically arranged rings provided a degree of tissue 
guidance. This resulted in oblique periodontal fibers attach-
ment into the dentin block similarly to that observed in native 
periodontal tissue, although this feature was only sporadi-
cally observed over the dentin surface, and therefore was not 
actuated in a controlled manner (Figure 6C).
While the aforementioned studies utilized state of the art 
additive manufacturing technologies for the fabrication of the 
biphasic TECs, autologous blood products combined with a 
calcium phosphate cement have also been proposed.[31] This 
approach consisted of creating a genipin cross-linked platelet 
lysate membrane supported by a calcium phosphate cement 
combined with hyaluronic acid microspheres loaded with 
platelet lysate. This TEC was implanted in a three-wall bone 
defect in rats with the hemoderivative membrane in direct 
contact with the root surface. The presence of the platelet mem-
brane appeared to have a beneficial impact over periodontal 
regeneration; however, the rapid degradation of the calcium 
phosphate cement compromised the global stability of the TEC 
and overall resulted in poor periodontal regeneration. An impor-
tant advantage to this approach is that the biphasic constructs 
were prepared using technologies which can be implemented 
by the periodontologist at the chairside using autologous mate-
rials. As a result, this approach has limited regulatory barriers 
from an FDA approval point of view and hence could be rapidly 
translated to the clinic if proven successful.
In the context of periodontal regeneration, biphasic scaf-
folds are generally designed to facilitate regeneration of the 
alveolar bone and periodontal ligament, however the deposition 
of a new cementum layer at the tooth interface is not actively 
addressed by these concepts. They rely either on the implanta-
tion of in vitro differentiated cells or on the capacity of endog-
enous cells to promote the apposition of new cementum on the 
tooth surface. Therefore, recent studies have started addressing 
the issue of actively promoting cementogenesis by incorpo-
rating a third layer, which is the cementum compartment, 
within the periodontal TECs.
3.2. Triphasic Scaffolds
Although the concept of triphasic scaffolds has been extensively 
studied for orthopedic applications, such as tendon, ligament 
or osteochondral tissue engineering, it remains rarely utilized 
for periodontal regeneration. However, the field is evolving 
rapidly and recent studies have reported on the development 
of triphasic scaffolds, created using either conventional scaffold 
fabrication technologies or additive manufacturing. Triphasic 
scaffolds only differ from their biphasic counterparts by the 
addition of an extra layer, usually targeted to cementum regen-
eration. While in the biphasic design, native cells or cells 
seeded in the periodontal compartment achieve cementum 
regeneration post-implantation, the triphasic concept involves 
the incorporation of a specific cementum compartment, con-
sisting of a biological cue/bioactive biomaterial, with the goal of 
actively triggering cementogenesis within this part of the TEC.
Adv. Healthcare Mater. 2018, 7, 1800457
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Following this concept, a hydrogel triphasic TEC was man-
ufactured utilizing a mixture of chitin, poly(lactic-co-glycolic 
acid), nanobioactive glass ceramic and various biological cues 
specific to the different compartments.[32] In this approach, 
each compartment was separately fabricated from a solu-
tion blend of chitin and nanobioglass particles, added in both 
the cementum and bone compartments in order to stimulate 
ECM mineralization. In addition, specific growth factors were 
subsequently incorporated within the individual compartments 
by adding a defined amount of cementum protein 1 (rhCEMP1), 
fibroblast growth factor 2 (FGF-2), and platelet derived growth 
factor in the cementum, periodontal ligament and bone com-
partments, respectively (Figure 7). Although the specific details 
of the compartment assembly were not reported, this approach 
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Figure 6. Additively manufactured biphasic scaffold. A) Bicompartment scaffold manufactured using a sacrificial mold, the specific features on the 
mold surface resulted in the creation of microchannels for fiber guiding, as demonstrated in vivo in a rodent periodontal defect. Reproduced with 
permission.[28] Copyright 2012, Elsevier. B) 3D-printed biphasic scaffold fabricated via fused deposition modeling and solution electrospinning com-
bined with three layers of cell sheets which promoted tissue attachment on a dentin slice. Reproduced with permission.[29] Copyright 2012, Elsevier. 
C) Similar design utilizing a melt electrospun scaffold with a larger pore size that enhanced the permeability and cross-talk between the bone and 
ligament compartments. The particular architecture of the melt electrospun membrane, made of concentrically organized rings, resulted in an ordered 
periodontal fiber orientation. Reproduced with permission.[30] Copyright 2014, John Wiley and Sons.
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created a stratified scaffold recapitulating both the architecture 
and the biochemical composition of the native periodontium. 
Further evaluation of the trilayered scaffold was performed 
using a surgically created defect around rabbit incisors. Despite 
the obvious limitations of the in vivo model, due to the use of 
continuously erupting incisors (a feature shared with many 
other rodents), the authors demonstrated some bone regenera-
tion, and new cementum tissue was deposited upon the incor-
poration of CEMP-1 in the cementum compartment of the 
triphasic scaffold (Figure 7). Interestingly, the success of this 
approach relied solely on the capacity of the host cells to facili-
tate tissue regeneration (instead of repair) which was induced 
by incorporating both bioceramic particles and growth factors 
into the various compartments. This cell-free approach has the 
advantage of potentially being more cost-effective (compared 
to cellularized TECs), as well as having fewer barriers for FDA 
approval and CE-marking, which are both important considera-
tions for clinical translation.
More recently, Varoni et al. reported the utilization of a 
trilayered chitosan scaffold fabricated by combining freeze 
drying (gingival and bone compartments) and electrochemical 
deposition (periodontal compartment).[33] This resulted in the 
manufacturing of a scaffold featuring aligned microchannels of 
450 µm width within the periodontal compartment. The regen-
erative potential of the trilayered scaffold was assessed using 
hPDL in a murine periodontal ectopic regeneration model. 
Histological assessment demonstrated significant mineraliza-
tion in the bone compartment, CEMP-1 positive mineralized 
nodules at the dentin interface and the presence of soft tissue 
intercalation between these mineralized tissues, hence resem-
bling the anatomical structure of the periodontium. Despite 
these promising findings, the soft tissue intercalation was 
mainly composed of collagen fibers running parallel to the 
dentin surface, with no functional attachment observed.[33]
Another example utilizing a triphasic scaffold for periodontal 
tissue engineering involved a continuous additive manufac-
turing process in order to incorporate both an architectural 
and biochemical gradient.[34] This scaffold comprised of three 
distinct yet fully integrated phases, recapitulating the trilay-
ered morphology of the native tissue: cementum, periodontal 
ligament layer and alveolar bone layers. Each layer displayed a 
specific architecture with a pore size of 100, 600, and 300 µm 
for the cementum, periodontal and bone compartments 
respectively, hence creating a hierarchical structure. Further 
to this architecturally stratified design, a biochemical compo-
sitional compartmentalization was achieved by incorporating 
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Figure 7. Triphasic scaffold utilizing both natural and synthetic materials for the delivery of biological cues in the various compartments. The three 
layers were manufactured separately, and subsequently assembled and tested using an incisor periodontal defect model in the rabbit. Each layer 
displayed a randomly organized porosity and allowed the release of specific biomolecules. In vivo testing demonstrated cementum, ligament, and 
new bone formation; however, the continuously erupting nature of the incisors does not necessarily enable a distinction between regeneration 
induced by the triphasic scaffold and natural tissue remodeling. Reproduced with permission.[32] Copyright 2017, Wiley-VCH. nBGC: nanobioactive 
glass ceramic; PLGA: poly(lactic-co-glycolic acid); FGF-2: fibroblast growth factor-2; PRP: platelet-rich plasma; C: cementum; P: periodontal ligament; 
B: alveolar bone.
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polyglycolic microspheres loaded with tissue specific growth 
factor, amelogenin (cementum compartment), connective 
tissue growth factor (periodontal ligament compartment) and 
BMP-2 (bone compartment) for controlled spatiotemporal 
delivery of biological cues hence favoring progenitor cell 
homing and recruitment. Even though the manufacturing of 
the scaffold was numerically controlled (as in every CAD/CAM 
methodology), the incorporation of the growth factors was per-
formed manually by pipetting the microspheres in each specific 
compartment, hence potentially inducing batch to batch varia-
tions. The performance of these TECs seeded with dental pulp 
stem/progenitor cells was tested in vivo using an ectopic rodent 
model (albeit without the presence of a dentin block). Discon-
tinuous cementum-like tissue formation was observed, while 
some level of mineralization was noted in the bone compart-
ment. A soft connective tissue was intercalated between these 
two mineralized tissues and displayed some attachment and 
alignment toward the cementum-like layer. Despite these prom-
ising ectopic regenerative outcomes, the design of the scaffold 
has limitations that may hinder clinical translation, such as 
poor adaptability to “real-world” periodontal defects, as well as 
scaffold excessive stiffness which could induce soft tissue perfo-
ration and subsequent exfoliation. Furthermore, as mentioned 
previously, the manual loading of the growth factors can induce 
large variation in the actual quantity incorporated within each 
compartment of the triphasic TEC. This later issue was cir-
cumvented by the authors of a recent study by directly loading 
the PLGA microspheres into the polymer melt utilized for 3D 
printing, albeit for a different application—temporomandibular 
joint reconstruction. Addressing potential limitations, mostly 
related to thermal degradation of the biological cues once 
exposed to the elevated temperatures required for extruding the 
polymer melt, the authors reported a protective effect from the 
PLGA, which reduced the heat transfer and hence prevented 
significant degradation of the biochemical cues.[35]
The utilization of a triphasic scaffold for periodontal regen-
eration is relatively recent and remains vastly unexplored 
as the clinical implementation of this approach may be chal-
lenging. Indeed, regenerative events should occur in a highly 
coordinated, sequential, and sometimes overlapping manner, 
whereby cementogenesis onto the dentin of the tooth and the 
formation of inserting new periodontal ligament fibers into 
this cementum occur concurrently in order to achieve the fully 
integrated, functional new periodontal attachment that mimics 
native tissue. While the incorporation of a cementum layer into 
the implanted TEC may appear to be conceptually sound, a 
major foreseeable challenge is the ability to fix and integrate a 
cementum layer onto the underlying dentin surface of the tooth 
root. In addition, the design of the triphasic scaffold does not 
necessarily take into consideration the anatomical dimensions 
of the cementum tissue, which is less than a hundred 
micrometers, whereas most cementum compartments reported 
in the literature are of thicknesses approaching the millimeter 
scale. This discrepancy could potentially result in the formation 
of tissue that is not anatomically relevant and hence could jeo-
pardize or impede periodontal regeneration and hence clinical 
translation.
This section has described the major advancements in the 
field of multiphasic construct manufacturing for periodontal 
regeneration, and has highlighted the advantages as well as 
the limitations of compartmentalized multiphasic scaffolds. 
While these approaches are scientifically sound, it is con-
ceivable that the coordinated healing events necessary for 
successful periodontal regeneration may also be achieved 
without the utilization of a biomaterial scaffold, through the 
implantation of cells embedded in their own mature extracel-
lular matrix.
4. Cell Sheets and Scaffold-Free Constructs
The literature overwhelmingly suggests that periodontal 
ligament fibroblasts are the best performing cell type for 
facilitating periodontal regeneration.[17,36] The positive out-
come toward tissue regeneration is intimately linked to ECM 
production during the in vitro cell differentiation phase prior 
to transplantation. This can be explained by two mechanisms 
which are likely to work in a synergistic manner: biomechan-
ical stabilization and biological cues. Indeed, the production of 
ECM which results in the formation of a cell sheet enables the 
stabilization of the cells once placed in the periodontal defect 
when compared to cells which are freely injected/delivered into 
the recipient site. These cells contribute directly to new tissue 
formation as previous described[17] but also act in an indirect 
manner via the release of biological cues.[37] Indeed, biological 
molecules, specific to the native PDL cell niche, which are 
secreted during the in vitro maturation of the cell sheet, are 
likely to significantly influence the regenerative process.
This concept was explored by Okano and co-workers in a 
series of papers whereby the efficacy of three-layered cell sheets 
was confirmed in various animal models and implantation sites 
(Figure 8A).[36,38] It was shown that PDL cell sheets could attach 
to ectopically implanted dentin slices, and promote sporadic 
formation of cementum-like tissue at the dentin interface.[38b] 
Further evidence of the beneficial effect of implanting cells 
embedded in a mature ECM network was attained by using a 
surgically created periodontal defect model in athymic rats.[38c,d] 
This demonstrated enhanced attachment of the regenerated 
periodontal ligament as early as 1 week postimplantation of the 
cell sheets.[38d] Observations at 4 weeks postsurgery confirmed 
the maturation of the periodontal ligament, as oblique collagen 
fibers were inserted into the newly formed cementum whereas 
only randomly organized repair tissue was observed at the 
contralateral side (controls without a cell sheet). In a different 
study, the cell sheets were implanted into periodontal dehis-
cence defects in the mandibular first premolars of canines, 
thus more closely resembling a clinical situation.[38a] In this 
approach, a hyaluronic acid membrane was utilized in order to 
support the trilayered cell sheets and to deliver the cellularized 
material onto the root surface. The authors reported that full 
periodontal regeneration, defined as the formation of alveolar 
bone, ligament and cementum, occurred in three of the five 
animals that received cell sheets. Functional PDL attachment 
was also attained in these three animals, with fibers inserting 
perpendicularly into newly formed cementum. In contrast, the 
defects without cell sheets displayed poor periodontal attach-
ment resulting in delamination of the tissue upon histological 
sectioning. Although the cell sheet significantly enhanced the 
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regenerative outcomes, two of the five animals displayed par-
tial or poor regeneration, and this was attributed to a lack of 
biomechanical stability of the cell sheets on the root surface. 
The cell sheets may have been displaced during suturing or 
subsequent mastication, thus resulting in impaired regen-
eration. In a subsequent study also using a canine model, a 
three-wall defect was created using trilayered cell sheets that 
were placed into this confined defect using a thin biodegrad-
able polyglycolic acid (PLGA) membrane, with the remainder 
of the defect filled with an inorganic filler.[38e] In this instance, 
good biomechanical stability of the cell sheet was achieved due 
to the confined nature of the three-wall defects, which resulted 
in full periodontal regeneration in all of the four animals. The 
cell sheets out-performed the control group in all parameters 
used to assess periodontal regeneration, including higher level 
of bone fill and new cementum deposition (Figure 8A). This 
study demonstrated the favorable performance of the in vitro 
engineered cell sheets containing an extensive extracellular 
network along with differentiated living cells.
More recently, a modified concept using cell spheroids 
formed from cell sheets has been proposed in order to further 
enhance the regenerative potential of this approach. The 
strategy behind the utilization of cell sheets relies, as described 
previously, on the implantation of an intact and extensive ECM 
network. Guo et al. developed a technique enabling the produc-
tion of cell pellets from trilayered cell sheets based on their spon-
taneous contraction, which resulted in the creation of highly 
viable cell pellets with increased ECM content when compared 
to noncontracted trilayered sheets. Although the mechanism 
behind the higher ECM production in the cell pellet remains 
unclear, there was a 20- to 30-fold increase in the collagen con-
tent. The regenerative performance of the cell sheets and cell 
pellets was assessed in a periodontal defect model created on 
the root of the rat maxillary first molar. This demonstrated that 
the increased content in ECM from the cell pellet resulted in 
higher mineralization within the defect and a higher degree 
of ligament alignment. The concept of implanting cell pellets 
was further investigated by Takewaki et al. using iliac crest 
mesenchymal stem cell spheroids differentiated in collagenic 
and/or osteogenic culture media prior to transplantation in a 
preclinical dog model[39] (Figure 8B). This strategy also relied 
on the extensive production of ECM for enabling mechanical 
manipulation of the cell sheet in order to create the cell pellet. 
As expected with cell spheroids, nutrient and oxygen diffusion 
was limited in the central portions, although significant cell 
apoptosis was only noted after 10 days of in vitro culture 
(Figure 8B). The spheroids, differentiated for 5 days in vitro, 
were subsequently implanted in a class III furcation defect in 
dog premolars and this resulted in significant regeneration of 
cementum, periodontal ligament and alveolar bone 12 weeks 
post-implantation. Apart from the inherent challenges related 
to the in vitro expansion of cells prior to implantation, which 
are of concern from both cost and regulatory perspectives, the 
handling and stabilization of the cell sheets or cell pellets in 
these scaffold-free approaches may be another major technical 
limitation. Further, poor biomechanical fixation that hinders 
cell sheet/pellet attachment on the root surface can be detri-
mental to subsequent regenerative outcomes, as previously 
discussed.
5. Future Outlook for Periodontal Regeneration
This review has provided an insight into the current scaffold 
designs and fabrication technologies with a focus on periodontal 
attachment and orientation. However, most of these recent 
developments are still in their early stages of translation to the 
clinic, and widespread clinical use still remains a challenge. 
In addition, clinical translation can be further impeded by 
the complexity of the scaffold design, which is required for 
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Figure 8. Scaffold-free periodontal regeneration. A) Utilization of trilayered cell sheets harvested from thermoresponsive culture dishes stacked 
together and placed in a three-wall periodontal defect in a canine. This approach demonstrated superior regeneration in the specimens where the cell 
sheets were implanted. Reproduced with permission.[38e] Copyright 2009, Elsevier. B) Utilization of cell spheroids created by the spontaneous contrac-
tion of cell sheets during in vitro osteogenic differentiation and implanted in a class III furcation defect resulting in full bone regeneration. Reproduced 
with permission.[39] Copyright 2009, SAGE Publications.
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a coordinated spatiotemporal regenerative response. The 
current trend in tissue engineering for periodontal regenera-
tion is to mimic the architectural and compositional features 
of the periodontium, therefore resulting in complex structures 
whereby the TEC manufacturing reproducibility may be 
challenging. Ultimately, the aim should be to design TECs 
that achieve positive clinical outcomes with as straightfor-
ward and cost-effective solutions as possible, but at the same 
time taking into account the complexities that are inherent to 
periodontal regeneration. Clinical translation could be acceler-
ated by combining such TECs with concurrent advances in sur-
gical techniques and other chairside approaches that are being 
continually developed to enhance regenerative outcomes.
The next section explores the future of periodontal regenera-
tion and addresses the advantages and issues associated with 
current strategies, and proposes innovative modifications for 
enhanced clinical outcomes.
5.1. Patient Specific Scaffolds
Scaffold modeling using computer-aided design software 
has allowed for an increase in their architectural complexity. 
Specifically, the use of computed tomography (CT) to extract 
the specific dimensions and topography of a given defect site 
holds promise for the potential development of patient-specific 
scaffolds that are based on patient-specific defect parameters.
A recent seminal single case report by Rasperini et al.[40] 
used cone beam computed tomography (CBCT) scans of a 
53 year old male’s peri-osseous defect to design a customized 
polycaprolactone scaffold fabricated via selective laser sintering. 
The scaffold consisted of an internal region with pegs to sup-
port PDL regeneration and the delivery of rhPDGF-BB, and an 
external region that would resorb over time with subsequent 
replacement by alveolar bone (Figure 9). In this first application 
of a 3D-printed scaffold specifically designed for the treatment 
of a periodontal defect, the PCL scaffold remained in situ for 
a period of 12 months without signs of dehiscence or chronic 
inflammation. However, the primary limitation was the use 
of a rather rigid construct made of a slow-degrading polymer 
(PCL) that possibly created a mechanical mismatch with the 
surrounding soft gingival tissue over time. This unfortunately 
resulted in the construct becoming exposed to the oral environ-
ment 13 months postimplantation, whereby it became contami-
nated by intraoral microbes and was lost.
The ongoing technological evolution of 3D printing now 
enables the utilization of a greater variety of materials with tai-
lorable mechanical and degradative properties (such as PLGA) 
while maintaining high printing resolution[41] necessary for 
manufacturing of customized scaffolds. Therefore, it will 
enable the fabrication of “softer” scaffolds with space mainte-
nance and degradative properties more suited to periodontal 
regeneration.
In addition to the customization of 3D constructs for perio-
dontal regeneration, another important aspect to consider is the 
utilization of medical grade material. For regulatory require-
ments, the use of traceable, high purity, and certified medical 
grade material is essential in order to ultimately enable clinical 
translation and commercialization of these medical devices.
5.2. Fiber Guidance
The specificity of scaffold architecture contributes to its ability 
to act as a biomaterial template for the guidance of oriented 
fiber formation that is critical to the regeneration of tissues that 
require alignment for proper function—such as the PDL. Fiber 
guiding is generally achieved by either topographically guiding 
the fiber orientation or by mechanically stimulating the cells 
prior to implantation in order to increase functional attachment 
of the periodontal ligament. The first approach utilized grooves 
of various widths for inducing a spontaneous alignment or a 
specific topographical organization as initially demonstrated 
by Park et al.[27,28] The fabrication of the fiber-guiding biphasic 
scaffold involved the casting of a polymer solution into a sacri-
ficial mold, resulting in a surface topography in the periodontal 
compartment which promoted the creation of aligned micro 
channels. A similar feature was also observed using melt 
electrospinning for the fabrication of a biphasic scaffold 
(Figure 6C), although minimal control over the physical 
arrangements of the channels (channel spacing, spatial distri-
bution, etc.) was possible with both of these techniques. Indeed, 
these fiber guidance features were imparted by the inherent 
nature of the fabrication techniques, without being specifically 
introduced for this purpose within the scaffold design.
As the development of scaffolds for periodontal tissue 
engineering has matured, different technologies have been 
developed for the introduction of guiding channels within the 
scaffold in a more systematic and controlled manner.[42] This 
was implemented by utilizing a directional cooling system 
which impacted on the heat transfer gradient and crystal 
growth direction of a gelatin solution resulting in the creation 
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Figure 9. Customized scaffold designed for a human peri-osseous defect 
based on a model derived from cone beam computed tomography scans. 
The polycaprolactone scaffold consisted of an internal region with pegs 
as a dedicated space for periodontal ligament regeneration, with the 
external region supporting the tooth root during alveolar bone regenera-
tion. The scaffold remained in place for a period of 1 year without signs 
of chronic inflammation or dehiscence. Reproduced with permission.[40] 
Copyright 2015, SAGE Publications.
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of microchannels of various orientation within a gelatin 
sponge,[42b] as shown in Figure 10A. Although, the microchan-
neled scaffold was not extensively tested in vitro or in vivo, its 
internal architecture strikingly resembled the native organiza-
tion of the collagen fibers within the periodontal ligament. Most 
recently, Park et al.[43] detailed a new method for the creation of 
angulated (parallel, oblique, and perpendicular) microgroove 
patterns using additive manufacturing, with in vitro confirma-
tion of predictable ligament cell alignment along the 3D-printed 
grooves. The resulting fiber-guiding regions can improve the 
ability of next generation scaffolds to promote a more accurate 
recapitulation of the PDL’s anatomical complexity.
Fiber guidance can also be obtained by combining several fab-
rication techniques such as electrospinning and freeze-drying. 
For example, thin PCL–PEG copolymer electrospun membranes 
consisting of aligned fibers were stacked on top of each other, 
infiltrated with a chitosan glue, and subsequently crosslinked and 
freeze-dried. This created a specific architecture of alternating 
electrospun mats and chitosan foam separated by a few hundred 
micrometers, hence forming a topography similar to microchan-
nels (Figure 10B). Although this specific topographical feature 
was obtained in a manual manner and can hence be prone to 
batch-to-batch and operator variation, the scaffold was shown to 
be effective at guiding periodontal orientation and attachment 
onto newly formed cementum in a rat periodontal regeneration 
model (despite the absence of any PCL–PEG material in the his-
tology sections provided in the paper).
A more systematic manner of providing guidance was 
recently reported by combining 3D printing and soft lithography 
for the fabrication of a scaffold with mesoscale and microscale 
topographical cues.[42c] In this approach, soft lithography was uti-
lized for the creation of a micropatterned thin PCL film featuring 
pillars with microgrooves of various widths (15 or 60 µm) and 
depths (10 and 30 µm) (Figure 11). The micro patterned mem-
brane was assembled with a scaffold fabricated via selective laser 
sintering (SLS) and the fiber guidance potential of the TEC was 
investigated in a murine subcutaneous model using a dentin 
slice. This demonstrated that the most prominent impact upon 
cell and tissue alignment was provided by the depth of the groove 
and that this effect, although detectable at an earlier time point, 
was more pronounced 6 week postimplantation. The authors fur-
ther reported an increase in the thickness of orientated collagen 
fibers reaching up to 50 µm with the deeper grooves, exceeding 
the actual dimension of the microscale features (Figure 11). 
Therefore, these results clearly showed that the topographical 
cues were effective not only within the grooves but also in their 
direct vicinity. While this approach represents a breakthrough 
in the field, several limitations are inherent to the TEC fabrica-
tion method and are related to the discontinuous topographical 
guidance provided by the pillars. The microgrooved film was 
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Figure 10. Fiber guiding scaffold for periodontal tissue engineering. A) Gelatin scaffold featuring orientated microchannels manufactured via a 
controlled bidirectional cooling of the gelatin solution. Reproduced with permission.[42b] Copyright 2014, SAGE Publications. B) Combination of thin 
electrospun mats glued together using a chitosan hydrogel leading to the creation of channels of various widths which demonstrated significant impact 
on orientating periodontal ligament fibers in a rodent model. Reproduced with permission.[42a] Copyright 2015, Elsevier.
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composed of 400 µm pillars evenly spaced every 400 µm, hence 
creating an interface consisting of alternating voids which ena-
bled tissue infiltration, and solid PCL pillars which impeded 
tissue infiltration. This configuration reduces the level of tissue 
adhesion to the dentin block as 25% of the micro patterned 
surface consisted of the PCL pillars. Although, the microgrooves 
were proven to be very efficient in inducing tissue alignment, 
this effect was restricted to the direct vicinity of the grooves 
and hence only a fraction of the regenerated tissue was actually 
affected. Notwithstanding these limitations, this study represents 
a significant step toward promoting the functional regeneration 
of the periodontal ligament and provides a foundation for future 
work aimed at developing fully integrated, compartmentalized 
and fiber guiding periodontal constructs.
As discussed here, the literature overwhelmingly suggests 
that physical and topographical cues are the way forward for 
enhancing periodontal fiber orientation; however, a recent 
report has demonstrated the efficacy of combining this 
approach with an in vitro mechanical preconditioning of the 
cells for promoting the orientation of the periodontal fibers.[44] 
In this approach, PDL cells seeded onto aligned electro-
spun fibers were subjected to biaxial stretching of around 6% 
strain at a frequency of 1 Hz for up to 10 days and resulted 
in upregulated expression of periodontal markers such as per-
iostin, tenascin and TGF-β. This effect was also translated in 
vivo and demonstrated that mechanically induced cell differen-
tiation was able to enhance periodontal attachment and bone 
apposition.
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Figure 11. Advanced design for the creation of a fiber guiding biphasic construct for periodontal regeneration. A patterned membrane featuring 
microgrooved pillars was utilized to induce a systematic in vivo alignment of the newly formed periodontal ligament. Reproduced with permission.[42c] 
Copyright 2016, Wiley-VCH.
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The maturation of cells in a bioreactor or using a dif-
ferentiation cocktail in order to guide their commitment 
toward differentiation can impart a significant increase in 
both reproducibility and costs. Other methods have proposed 
to directly influence the cell differentiation in vivo via the 
functionalization of the scaffold.
5.3. Scaffold Functionalization
5.3.1. Gene Therapy
As discussed earlier, periodontal wound healing can be 
enhanced through the use of recombinant growth factors 
(GFs) and platelet-rich plasma which contain concentrated 
suspensions of autologous platelets that secrete bioactive GFs 
at the wound site. Some commonly used bioactive agents in 
the clinic are derived from the following GF families: platelet 
derived growth factors, bone morphogenetic proteins (BMPs) 
within the β-transforming growth factor (β-TGF) superfamily 
and fibroblast growth factors (FGFs), among others. These 
biologics regulate periodontal and mesenchymal stem cell 
migration, differentiation, proliferation, chemotaxis, and cell-
specific extracellular matrix (ECM) production. The efficacy 
of these agents varies depending on delivery system, dosages, 
and release kinetics. Pharmacologic dosing is often required 
to mitigate the transient biological activity of GFs at local 
delivery sites due to short half-lives and proteolytic degrada-
tion, although use of these supra-physiological doses can evoke 
local and systemic toxicity.[45] Localized GF delivery is therefore 
necessary to decrease total dosage needed without compro-
mising function, and 3D TECs have been utilized as a delivery 
strategy with various degrees of success, as described earlier in 
this review.
Gene therapy provides a promising strategy to achieve greater 
bioavailability of growth factors within periodontal defects, cir-
cumventing the limitations of the short growth factor half-lives 
and the resultant necessity for the local delivery of potentially 
toxic supra-physiological doses. The gene therapy approach 
involves the transduction (using viral elements) or transfection 
(using nonviral elements) of a target cell population to express 
GF-encoding genes over the time-frame necessary to achieve 
the desired therapeutic effects.
Viral vectors used for gene therapy have included adenovi-
ruses (Ad), lentiviruses, retroviruses, adeno-associated viruses 
(AAVs), and baculoviruses (Figure 12). All have their own 
advantages and disadvantages, with viruses that have higher 
transduction rates also contributing to higher risk for host 
immunogenicity. For example, adenoviruses have high transduc-
tion rates, with the ability to transfect a large variety of different 
cell types; however, these is also potential for higher host 
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Figure 12. A variety of viral (i.e., adenovirus, retrovirus, adeno-associated virus) and nonviral (i.e., plasmid) vectors have been used for the delivery 
of various growth factors (i.e., platelet-derived growth factor, bone morphogenetic protein, and fibroblast growth factor) to elicit a local effect 
(i.e., cell differentiation, proliferation, etc.) that can promote periodontal regeneration. Cells can be transduced (using viral vector) or transfected 
(using a nonviral vector) and the cells and/or growth factors can be delivered using a variety of methods, including via a scaffolding matrix that can 
be implanted at the defect site. Reproduced with permission.[46] Copyright 2016, SAGE Publications.
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immunogenicity compared to other types of vectors. AAVs have 
the added advantage of being able to transduce both dividing 
and nondividing cells with low levels of immunogenicity, but 
with lower rates of transduction compared to adenoviruses. 
Another concern is that of insertional mutagenesis, which 
occurs when viral DNA integrates within the genome of a host 
organism; this is a risk with the use of lentiviruses, as well as 
retroviruses, whose transduction is also limited to dividing 
cells, although there is low risk of immunogenicity.[46] Safety 
concerns regarding risk of virus dispersion, cytotoxicity, and 
lack of spatiotemporal control of gene expression limit the pre-
dictability of viral vector use for gene therapy and in particular 
hamper its translation into clinically viable solutions, thereby 
requiring the investigation of novel methods of gene delivery. 
Currently, a safer alternative is the use of nonviral vectors such 
as plasmids, which have lower host immunogenicity, as well 
as reduced production costs compared to viral vectors. The 
main drawback of nonviral vectors, however, is their reduced 
efficiency of gene delivery (i.e., low transfection efficiency), 
resulting in more transient expression.[47]
Various methods of viral and nonviral vector delivery have 
been employed to elicit a local regenerative response through 
induced growth factor expression (Figure 12). Multiple studies 
support the potential use of gene therapy for periodontal tissue 
regeneration. Sustained and localized PDGF-B gene expression 
using direct delivery in periodontal lesions was observed for up 
to 21–35 days after cell transduction,[48] and has been shown 
to stimulate alveolar bone and cementum regeneration,[49] 
whereas ex vivo BMP-7 gene transfer using dermal fibroblast 
transduction resulted in predictable bridging of periodontal 
bone defects.[50]
Scaffolds can also serve as delivery vehicles for transduced 
cells. Biphasic calcium phosphate block scaffolds have been 
used for the delivery of human periodontal ligament stem cells 
transduced with recombinant Ad-BMP2; mesoporous BioGlass/
silk scaffolds for delivery of AdBMP7 and/or AdPDGF-B, 
whose combination was shown to promote wound healing syn-
ergistically; and chitosan thermosensitive hydrogel scaffolds for 
delivery of BMP2 plasmid DNA-loaded nanoparticles into rat 
calvarial defects, resulting in enhanced bone formation.[51]
Overall, tissue engineering approaches using scaffolds alone 
or in combination with growth factor, cell and/or gene delivery 
have the potential to address existing challenges in managing 
periodontal tissue loss and increase clinical options for their 
controllable regeneration. Given the limitations of current peri-
odontal regenerative therapies, a scaffold-based delivery vehicle 
that can be used for the regeneration of the alveolar bone–PDL–
cementum complex in conjunction with localized, controlled 
PDGF-BB and BMP-7 delivery using gene therapy is relevant 
to making further progress in creating the next generation of 
tissue engineered scaffolds for PDL regeneration.
Decellularized Extracellular Matrix: Another method of 
functionalizing synthetic scaffolds utilizes the concept of 
decellularization. Tissue decellularization is a recognized 
and well established method for the manufacturing of bio-
logical scaffolds which properties can affect a great variety 
or cellular function from migration, proliferation and ulti-
mately differentiation,[52] and has been shown to affect the 
polarization of macrophages.[53] Decellularized matrices are 
widely used in a plethora of applications ranging from soft 
tissue healing to breast and tendon regeneration, and in den-
tistry in the form of membranes for guided bone and tissue 
regeneration.[54]
The preservation of the ECM components along with the 
biochemical cues present in the ECM network is central to the 
success of the regenerative outcome. As such, mild chemicals 
are preferably utilized in order to achieve decellularization with 
minimal impact on the ECM. The utilization of this technique 
has recently been proposed for periodontal regeneration.[55] 
This strategy consisted in developing a mature ECM via the in 
vitro culture of periodontal cells under differentiation media 
prior to harvesting using a melt electrospun membrane (similar 
to that shown in Figure 3B) and subsequent decellularization 
using ammonium hydroxide and DNAse treatment. This mild 
chemical treatment enabled the maintenance of the collagen 
network AND the preservation of resident growth factors, which 
supported the repopulation of the TEC with allogenic cells. The 
decellularized TEC was further assessed in a surgically created 
rat periodontal defect and demonstrated some encouraging 
in vivo outcomes.[56] This methodology could circumvent the 
issues associated with patient specific cell implantation and 
provide clinicians with an off-the-shelf product.
5.3.2. Scaffold with Immunomodulatory Properties
The designing of scaffolds with immunomodulatory capacity 
has been the focus of extensive research. This can be achieved 
by the modification of the surface of the biomaterials as stem 
cells and inflammatory cells are known to be affected by the 
roughness, the size and shape of topographical cues. Indeed, 
smoother PLGA spheres have been demonstrated to reduce 
the level of inflammation[57] and elongated PLGA particles 
increased the proliferation of T-cells when compared to PLGA 
spheres.[58] Although the surface modification on microspheres 
or 2D films is efficient at better controlling the activation of 
inflammatory cells, its implementation in 3D scaffolds remains 
elusive due the technical hurdles in translating the fabrication 
methods from 2D to highly porous scaffolds. Another inter-
esting strategy involved the addition of biological cues within 
the TECs. As TNFα is a major proinflammatory molecule, 
strategies have sought to inactivate its in vivo action by incor-
porating antibodies targeted toward this cytokine in biomate-
rials.[59] Direct impact on the inflammatory process was also 
achieved by the incorporation of pro-healing cytokines[60] and 
via the utilization of pro-resolution molecules such as resolving 
D1.[61] In the latter case of resolving D1, a significant impedi-
ment is the poor stability of the molecule, which could decrease 
its efficacy during clinical use.
5.4. Cellular Therapy and Clinical Trials
Cell sheet tissue engineering is one of the most advanced tissue 
engineering methodologies for periodontal regeneration and 
several clinical trials have been conducted in recent years.[62] 
The pioneering group in the field reported the initiation of a 
clinical trial in 2011, with 10 patients recruited by 2014.[63] 
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While the outcomes of this particular clinical trial have not yet 
been reported, it is interesting to elaborate on the regulatory 
considerations for such a trial. Iwata et al. described some of 
the many requirements for the fabrication of the clinical grade 
cell sheets which are based on good clinical practice (GCP) 
and good manufacturing practice (GMP).[64] To achieve this, a 
GMP compliant cell processing unit was built, the cells were 
cultured using GMP-grade reagents or certified chemicals and 
under xeno-free condition (using uniquely autologous serum) 
resulting in tremendously high production costs.[65] There-
fore, one can question the economic viability of this technique 
especially in light of a recently reported clinical trial which dem-
onstrated that the cell sheet, although safe to use, had little to 
no impact on the regenerative outcomes.[62] Hence, the require-
ment for the expansion and transplantation of living cells with 
this approach imparts a significant economic burden which 
may prevent successful commercial translation to the clinic. 
The high economic cost of the treatment may also be difficult 
to justify in the context of a noncritical, nonlife threatening 
medical condition.
Other approaches, still utilizing autologous biological 
components, could nevertheless be implemented for circum-
venting the regulatory issues and mitigating the high costs 
associated with cell expansion in a GMP cell processing facility.
5.5. Autologous Derived Biochemical Cues
Autologous blood products, such as platelet-rich plasma, 
platelet-poor plasma (PPP) and platelet-rich fibrin (PRF), 
are commonly used for several applications in dentistry and 
regenerative medicine, and they have been applied with some 
mitigated success for periodontal regeneration.[31] The clinical 
application and effectiveness of these approaches has been 
reviewed extensively elsewhere.[66] A further development in 
autologous preparations for regenerative medicine has seen 
the emergence of extracellular vesicles (EVs) as a potent means 
for influencing the initial inflammatory response and the 
subsequent healing events in tissue engineering and regenera-
tive medicine applications.[67] EVs are a category of endocytic 
produced vesicles containing biological information in the form 
of siRNA, protein, growth factors, and hence have the capacity 
to facilitate paracrine communication between distant cells[68] 
These effectors, isolated from platelet lysate or secreted from 
cells in vitro, have been shown to significantly impact cell 
differentiation in vitro and in vivo.[69] These recent findings also 
suggested that exosomes are capable of binding to ECM such 
as type I collagen and fibronectin and therefore can be easily 
combined with biomaterials for effective in vivo local delivery, 
as recently demonstrated.[70] This could be achieved by either 
decorating a synthetic multiphasic scaffold with exosomes or by 
encapsulating them into a hydrogel prior to implantation.
6. Conclusion
Due to their ability to mimic the complex hierarchical 
structure of the periodontium, 3D tissue engineered constructs 
offer promising opportunities for promoting periodontal 
regeneration. This review has outlined the significant advances 
that have been achieved over the past couple of decades, cul-
minating in the development of functionalized multiphasic 
scaffolds that show promising results in preclinical trials. 
Building on preclinical research conducted over the past 
10 years, 3D tissue engineered constructs for periodontal 
regeneration are beginning to be translated to clinical applica-
tions. While early “proof-of-principle” reports of application in 
human subjects are encouraging, there is clearly a need for fur-
ther optimization and refinement of current strategies before 
they can be applied to routine clinical care. Initially, it is likely 
that customized multiphasic 3D TECs, functionalized with 
either autologous preparations that could be obtained chairside 
or regulator approved commercially available bioactive agents, 
will provide the most feasible pathway for clinical translation 
toward predictable periodontal regeneration.
Acknowledgements
C.V. was supported by the Queensland University of Technology Vice-
Chancellor-Research-Fellowship. S.P. was supported by the University 
of Michigan Rackham Merit Fellowship and the NIH/NIDCR Tissue 
Engineering at Michigan (TEAM) trainee grant (DE 007057). W.V.G. was 
supported by NIH/NIDCR RO1 DE 13397 and U24 DE026915. D.W.H. 
would like to acknowledge support from the Australian Research Council 
under the ARC Training Centre in Additive Biomanufacturing. S.I. and 
P.M.B. were supported by NHMRC project grant 1086181.
Conflict of Interest
The authors declare no conflict of interest.
Keywords
additive manufacturing, periodontal regeneration, scaffolds, tissue 
engineering
Received: April 26, 2018
Revised: July 3, 2018
Published online: August 26, 2018
[1] J. M. Albandar, T. E. Rams, Periodontology 2000 2002, 29, 207.
[2] L. Winning, G. J. Linden, BDJ Team 2015, 2, 15163.
[3] a) W. G. Skillen, G. R. Lundquist, J. Am. Dent. Assoc. Dent. Cosmos 
1937, 24, 175; b) W. V. Giannobile, J. Periodontol. 2014, 85, 1151.
[4] A. H. Melcher, J. Periodontol. 1976, 47, 256.
[5] a) B. Ellegaard, T. Karring, R. Davies, H. Loe, J. Periodontol. 1974, 45, 
368; b) B. Ellegaard, T. Karring, M. Listgarten, H. Löe, J. Periodontol. 
1973, 44, 209; c) B. Ellegaard, T. Karring, H. Löe, J. Clin. Periodontol. 
1976, 3, 23; d) B. Ellegaard, T. Kauring, H. Löe, J. Clin. Periodontol. 
1974, 1, 75.
[6] J. Caton, S. Nyman, H. Zander, J. Clin. Periodontol. 1980, 7, 224.
[7] a) S. Nyman, J. Lindhe, T. Karring, H. Rylander, J. Clin. Periodontol. 
1982, 9, 290; b) S. Nyman, J. Gottlow, T. Karring, J. Lindhe, 
J. Clin. Periodontol. 1982, 9, 257.
[8] a) J. Gottlow, S. Nyman, J. Lindhe, T. Karring, J. Wennström, 
J. Clin. Periodontol. 1986, 13, 604; b) J. Gottlow, S. Nyman, 
T. Karring, J. Lindhe, J. Clin. Periodontol. 1984, 11, 494.
Adv. Healthcare Mater. 2018, 7, 1800457
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800457 (19 of 20)
www.advancedsciencenews.com www.advhealthmat.de
[9] I. Needleman, H. V. Worthington, E. Giedrys-Leeper, R. Tucker, 
Cochrane Database Syst. Rev. 2006, 2, CD001724.
[10] P. Cortellini, G. P. Prato, M. S. Tonetti, J. Periodontol. 1996, 67, 
217.
[11] K. G. Murphy, J. C. Gunsolley, Ann. Periodontol. 2003, 8, 266.
[12] H. Nowzari, E. S. MacDonald, J. Flynn, R. M. London, 
J. L. Morrison, J. Slots, J. Periodontol. 1996, 67, 694.
[13] a) S. Ivanovski, C. Vaquette, S. Gronthos, D. W. Hutmacher, 
P. M. Bartold, J. Dent. Res. 2014, 93, 1212; b) S. Ivanovski, 
Aust. Dent. J. 2009, 54, S118.
[14] M. S. Tonetti, G. P. Prato, P. Cortellini, J. Clin. Periodontol. 1996, 23, 
548.
[15] D. Akita, M. Morokuma, Y. Saito, K. Yamanaka, Y. Akiyama, 
M. Sato, T. Mashimo, T. Toriumi, Y. Arai, T. Kaneko, N. Tsukimura, 
K. Isokawa, T. Ishigami, M. J. Hond, Biomed. Res. 2014, 35, 91.
[16] S. Baba, Y. Yamada, A. Komuro, Y. Yotsui, M. Umeda, 
K. Shimuzutani, S. Nakamura, Stem Cells Int. 2016, 2016, 7.
[17] H. Dan, C. Vaquette, A. G. Fisher, S. M. Hamlet, Y. Xiao, 
D. W. Hutmacher, S. Ivanovski, Biomaterials 2014, 35, 113.
[18] P.-C. Chang, A. S. Dovban, L. P. Lim, L. Y. Chong, M. Y. Kuo, 
C.-H. Wang, Biomaterials 2013, 34, 9990.
[19] P. C. Chang, M. C. Chung, C. Lei, L. Y. Chong, C. H. Wang, 
J. Biomed. Mater. Res., Part A 2012, 100A, 2970.
[20] H. Cho, S. Tarafder, M. Fogge, K. Kao, C. H. Lee, Connect. Tissue 
Res. 2016, 57, 488.
[21] A. Mathew, C. Vaquette, S. Hashimi, I. Rathnayake, F. Huygens, 
D. W. Hutmacher, S. Ivanovski, Adv. Healthcare Mater. 2017, 6, 
1601345.
[22] D. Puppi, C. Migone, L. Grassi, A. Pirosa, G. Maisetta, G. Batoni, 
F. Chiellini, Polym. Int. 2016, 65, 631.
[23] P. Chantarawaratit, P. Sangvanich, W. Banlunara, K. Soontornvipart, 
P. Thunyakitpisal, J. Periodontal Res. 2014, 49, 164.
[24] E. C. Carlo-Reis, A. P. B. Borges, M. V. F. Araújo, V. C. Mendes, 
L. Guan, J. E. Davies, Biomaterials 2011, 32, 9244.
[25] J. F. Requicha, C. A. Viegas, S. Hede, I. B. Leonor, R. L. Reis, 
M. E. Gomes, J. Tissue Eng. Regener. Med. 2016, 10, 392.
[26] J. F. Requicha, C. A. Viegas, F. Muñoz, J. M. Azevedo, I. B. Leonor, 
R. L. Reis, M. E. Gomes, Tissue Eng., Part A 2014, 20, 2483.
[27] C. H. Park, H. F. Rios, Q. Jin, J. V. Sugai, M. Padial-Molina, 
A. D. Taut, C. L. Flanagan, S. J. Hollister, W. V. Giannobile, 
Biomaterials 2010, 33, 137.
[28] C. H. Park, H. F. Rios, Q. Jin, J. V. Sugai, M. Padial-Molina, 
A. D. Taut, C. L. Flanagan, S. J. Hollister, W. V. Giannobile, 
Biomaterials 2012, 33, 137.
[29] C. Vaquette, W. Fan, Y. Xiao, S. Hamlet, D. W. Hutmacher, 
S. Ivanovski, Biomaterials 2012, 335560.
[30] P. F. Costa, C. Vaquette, Q. Zhang, R. L. Reis, S. Ivanovski, 
D. W. Hutmacher, J. Clin. Periodontol. 2014, 41, 283.
[31] P. S. Babo, X. Cai, A. S. Plachokova, R. L. Reis, J. Jansen, 
M. E. Gomes, X. F. Walboomers, J. Tissue Eng. Regener. Med. 2017, 
12, e1277.
[32] S. Sowmya, U. Mony, P. Jayachandran, S. Reshma, R. A. Kumar, 
H. Arzate, S. V. Nair, R. Jayakumar, Adv. Healthcare Mater. 2017, 6, 
1601251.
[33] E. M. Varoni, S. Vijayakumar, E. Canciani, A. Cochis, L. De Nardo, 
G. Lodi, L. Rimondini, M. Cerruti, J. Dent. Res. 2018, 97, 303.
[34] C. H. Lee, J. Hajibandeh, T. Suzuki, A. Fan, P. Shang, J. J. Mao, 
Tissue Eng., Part A 2014, 20, 1342.
[35] K. Legemate, S. Tarafder, Y. Jun, C. H. Lee, J. Dent. Res. 2016, 95, 
800.
[36] Y. Tsumanuma, T. Iwata, K. Washio, T. Yoshida, A. Yamada, 
R. Takagi, T. Ohno, K. Lin, M. Yamato, I. Ishikawa, T. Okano, 
Y. Izumi, Biomaterials 2011, 32, 5819.
[37] N. Yu, A. L. J. J. Bronckers, D. A. W. Oortgiesen, X. Yan, J. A. Jansen, 
F. Yang, X. F. Walboomers, Tissue Eng., Part A 2015, 21, 166.
[38] a) T. Akizuki, S. Oda, M. Komaki, H. Tsuchioka, N. Kawakatsu, 
A. Kikuchi, M. Yamato, T. Okano, I. Ishikawa, J. Periodontal Res. 
2005, 40, 245; b) M. Gomez Flores, M. Hasegawa, M. Yamato, 
R. Takagi, T. Okano, I. Ishikawa, J. Periodontal Res. 2008, 43, 364; 
c) M. Gomez Flores, R. Yashiro, K. Washio, M. Yamato, T. Okano, 
I. Ishikawa, J. Clin. Periodontol. 2008, 35, 1066; d) M. Hasegawa, 
M. Yamato, A. Kikuchi, T. Okano, I. Ishikawa, Tissue Eng. 2005, 11, 
469; e) T. Iwata, M. Yamato, H. Tsuchioka, R. Takagi, S. Mukobata, 
K. Washio, T. Okano, I. Ishikawa, Biomaterials 2009, 30, 2716; 
f) Y. Tsumanuma, T. Iwata, A. Kinoshita, K. Washio, T. Yoshida, 
A. Yamada, R. Takagi, M. Yamato, T. Okano, Y. Izumi, BioRes. Open 
Access 2016, 5, 22.
[39] M. Takewaki, M. Kajiya, K. Takeda, S. Sasaki, S. Motoike, N. Komatsu, 
S. Matsuda, K. Ouhara, N. Mizuno, T. Fujita, H. Kurihara, J. Dent. Res. 
2017, 96, 984.
[40] G. Rasperini, S. P. Pilipchuk, C. L. Flanagan, C. H. Park, 
G. Pagni, S. J. Hollister, W. V. Giannobile, J. Dent. Res. 2015, 94, 
153s.
[41] T. Guo, T. R. Holzberg, C. G. Lim, F. Gao, A. Gargava, 
J. E. Trachtenberg, A. G. Mikos, J. P. Fisher, Biofabrication 2017, 9, 
024101.
[42] a) W. Jiang, L. Li, D. Zhang, S. Huang, Z. Jing, Y. Wu, Z. Zhao, 
L. Zhao, S. Zhou, Acta Biomater. 2015, 25, 240; b) C. H. Park, 
K. H. Kim, H. F. Rios, Y. M. Lee, W. V. Giannobile, Y. J. Seol, 
J. Dent. Res. 2014, 93, 1304; c) S. P. Pilipchuk, A. Monje, Y. Jiao, 
J. Hao, L. Kruger, C. L. Flanagan, S. J. Hollister, W. V. Giannobile, 
Adv. Healthcare Mater. 2016, 5, 676.
[43] C. H. Park, K. H. Kim, Y. M. Lee, W. V. Giannobile, Y. J. Seol, 
Int. J. Mol. Sci. 2017, 18, 1927.
[44] J.-H. Kim, M. S. Kang, M. Eltohamy, T.-H. Kim, H.-W. Kim, PLoS 
One 2016, 11, e0149967.
[45] S. Elangovan, N. Karimbux, J. Biomater. Appl. 2010, 25, 3.
[46] L. Larsson, A. M. Decker, L. Nibali, S. P. Pilipchuk, T. Berglundh, 
W. V. Giannobile, J. Dent. Res. 2016, 95, 255.
[47] H. F. Rios, Z. Lin, B. Oh, C. H. Park, W. V. Giannobile, J. Periodontol. 
2011, 82, 1223.
[48] P. C. Chang, J. A. Cirelli, Q. Jin, Y. J. Seol, J. V. Sugai, N. J. D’Silva, 
T. E. Danciu, L. A. Chandler, B. A. Sosnowski, W. V. Giannobile, 
Hum. Gene Ther. 2009, 20, 486.
[49] a) P. C. Chang, Y. J. Seol, J. A. Cirelli, G. Pellegrini, Q. Jin, 
L. M. Franco, S. A. Goldstein, L. A. Chandler, B. Sosnowski, 
W. V. Giannobile, Gene Ther. 2010, 17, 95; b) Q. Jin, 
O. Anusaksathien, S. A. Webb, M. A. Printz, W. V. Giannobile, 
Mol. Ther. 2004, 9, 519.
[50] S. A. Hacking, A. Khademhosseini, J. Dent. Res. 2009, 88, 409.
[51] a) H. Li, Q. Ji, X. Chen, Y. Sun, Q. Xu, P. Deng, F. Hu, J. Yang, 
J. Biomed. Mater. Res., Part A 2017, 105, 265; b) T. Yi, C. M. Jun, 
S. J. Kim, J. H. Yun, Tissue Eng., Part A 2016, 22, 501; c) Y. Zhang, 
R. J. Miron, S. Li, B. Shi, A. Sculean, X. Cheng, J. Clin. Periodontol. 
2015, 42, 262.
[52] a) N. Sadr, B. E. Pippenger, A. Scherberich, D. Wendt, S. Mantero, 
I. Martin, A. Papadimitropoulos, Biomaterials 2012, 33, 5085;  
b) Z. Yin, X. Chen, T. Zhu, J.-J. Hu, H.-X. Song, W.-L. Shen, 
L.-Y. Jiang, B. C. Heng, J.-F. Ji, H.-W. Ouyang, Acta Biomater. 2013, 
9, 9317.
[53] D. M. Faulk, R. Londono, M. T. Wolf, C. A. Ranallo, C. A. Carruthers, 
J. D. Wildemann, C. L. Dearth, S. F. Badylak, Biomaterials 2014, 35, 
8585.
[54] a) P. M. Bartold, S. Gronthos, S. Ivanovski, A. Fisher, 
D. W. Hutmacher, J. Periodontal Res. 2016, 51, 1; b) I. Darby, 
Aust. Dent. J. 2011, 56, 107.
[55] a) A. Farag, C. Vaquette, D. W. Hutmacher, P. M. Bartold, 
S. Ivanovski, Methods Mol. Biol. 2017, 1537, 403; b) A. Farag, 
S. M. Hashimi, C. Vaquette, F. Z. Volpato, D. W. Hutmacher, 
S. Ivanovski, Arch. Oral Biol. 2018, 88, 67.
Adv. Healthcare Mater. 2018, 7, 1800457
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800457 (20 of 20)
www.advancedsciencenews.com www.advhealthmat.de
[56] A. Farag, S. Hashimi, C. Vaquette, M. Bartold, D. W. Hutmacher, 
S. Ivanovski, J. Clin. Periodontol. 2018, 45, 586.
[57] C. A. Vaine, M. K. Patel, J. Zhu, E. Lee, R. W. Finberg, R. C. Hayward, 
E. A. Kurt-Jones, J. Immunol. 2013, 190, 3525.
[58] J. C. Sunshine, K. Perica, J. P. Schneck, J. J. Green, Biomaterials 
2014, 35, 269.
[59] a) K. S. Foong, R. Patel, A. Forbes, R. M. Day, Tissue Eng., Part C 
2010, 16, 855; b) S. Marquette, C. Peerboom, A. Yates, L. Denis, 
I. Langer, K. Amighi, J. Goole, Int. J. Pharm. 2014, 470, 41.
[60] V. Carvalho, P. Castanheira, T. Q. Faria, C. Gonçalves, P. Madureira, 
C. Faro, L. Domingues, R. M. M. Brito, M. Vilanova, M. Gama, 
Int. J. Pharm. 2010, 400, 234.
[61] a) D. P. Vasconcelos, M. Costa, I. F. Amaral, M. A. Barbosa, A. P. Águas, 
J. N. Barbosa, Biomaterials 2015, 53, 566; b) D. P. Vasconcelos, 
M. Costa, I. F. Amaral, M. A. Barbosa, A. P. Águas, J. N. Barbosa, 
Biomaterials 2015, 37, 116.
[62] F.-M. Chen, L.-N. Gao, B.-M. Tian, X.-Y. Zhang, Y.-J. Zhang, 
G.-Y. Dong, H. Lu, Q. Chu, J. Xu, Y. Yu, R.-X. Wu, Y. Yin, S. Shi, 
Y. Jin, Stem Cell Res. Ther. 2016, 7, 33.
[63] T. Iwata, K. Washio, T. Yoshida, I. Ishikawa, T. Ando, M. Yamato, 
T. Okano, in New Trends in Tissue Engineering and Regenerative 
Medicine – Official Book of the Japanese Society for Regenerative 
Medicine (Eds: H. Hibi, M. Ueda), InTech, Rijeka 2014, Ch. 1.
[64] T. Iwata, K. Washio, T. Yoshida, I. Ishikawa, T. Ando, M. Yamato, 
T. Okano, J. Tissue Eng. Regener. Med. 2015, 9, 343.
[65] T. Yoshida, K. Washio, T. Iwata, T. Okano, I. Ishikawa, Int. J. Dent. 
2012, 2012, 8.
[66] a) G. Fernandes, S. Yang, Bone Res. 2016, 4, 16036; b) X. Hou, 
J. Yuan, A. Aisaiti, Y. Liu, J. Zhao, BMC Oral Health 2016, 
16, 71.
[67] T. N. Lamichhane, S. Sokic, J. S. Schardt, R. S. Raiker, J. W. Lin, 
S. M. Jay, Tissue Eng., Part B 2015, 21, 45.
[68] M. Yáñez-Mó, P. R. M. Siljander, Z. Andreu, A. B. Zavec, F. E. Borràs, 
E. I. Buzas, K. Buzas, E. Casal, F. Cappello, J. Carvalho, E. Colás, 
A. C.-d. Silva, S. Fais, J. M. Falcon-Perez, I. M. Ghobrial, B. Giebel, 
M. Gimona, M. Graner, I. Gursel, M. Gursel, N. H. H. Heegaard, 
A. Hendrix, P. Kierulf, K. Kokubun, M. Kosanovic, V. Kralj-Iglic, 
E.-M. Krämer-Albers, S. Laitinen, C. Lässer, T. Lener, E. Ligeti, 
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